NO972771L - Ny reseptor - Google Patents

Ny reseptor

Info

Publication number
NO972771L
NO972771L NO972771A NO972771A NO972771L NO 972771 L NO972771 L NO 972771L NO 972771 A NO972771 A NO 972771A NO 972771 A NO972771 A NO 972771A NO 972771 L NO972771 L NO 972771L
Authority
NO
Norway
Prior art keywords
binds
compound
tissue
brain tissue
rat
Prior art date
Application number
NO972771A
Other languages
English (en)
Norwegian (no)
Other versions
NO972771D0 (no
Inventor
Hugh Jonathan Herdon
Jeffrey Clifford Jerman
Wai Ngor Chan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO972771D0 publication Critical patent/NO972771D0/no
Publication of NO972771L publication Critical patent/NO972771L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO972771A 1994-12-17 1997-06-16 Ny reseptor NO972771L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9425502.3A GB9425502D0 (en) 1994-12-17 1994-12-17 Novel receptor
PCT/EP1995/004998 WO1996018650A1 (en) 1994-12-17 1995-12-11 Novel receptor

Publications (2)

Publication Number Publication Date
NO972771D0 NO972771D0 (no) 1997-06-16
NO972771L true NO972771L (no) 1997-08-15

Family

ID=10766105

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972771A NO972771L (no) 1994-12-17 1997-06-16 Ny reseptor

Country Status (15)

Country Link
US (1) US5985334A (xx)
EP (1) EP0807122A1 (xx)
JP (1) JPH10511083A (xx)
CN (1) CN1175262A (xx)
AU (1) AU710150B2 (xx)
BR (1) BR9510060A (xx)
CA (1) CA2207921A1 (xx)
CZ (1) CZ187697A3 (xx)
FI (1) FI972558A0 (xx)
GB (1) GB9425502D0 (xx)
HU (1) HUT77077A (xx)
NO (1) NO972771L (xx)
NZ (1) NZ298059A (xx)
PL (1) PL320747A1 (xx)
WO (1) WO1996018650A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245893B1 (en) * 1994-12-17 2001-06-12 Smithkline Beecham P.L.C. Receptor that binds anti-convulsant compounds
WO2021179064A1 (en) * 2020-03-10 2021-09-16 Epic Ventures Inc. Light-activated pathogen-killing molecules and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
GB9225860D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
WO1995006117A1 (en) * 1993-08-20 1995-03-02 Smithkline Beecham Plc Human 5-ht2 receptor

Also Published As

Publication number Publication date
US5985334A (en) 1999-11-16
MX9704560A (es) 1997-10-31
NO972771D0 (no) 1997-06-16
AU4345896A (en) 1996-07-03
CN1175262A (zh) 1998-03-04
EP0807122A1 (en) 1997-11-19
NZ298059A (en) 2000-03-27
HUT77077A (hu) 1998-03-02
BR9510060A (pt) 1998-06-02
CZ187697A3 (en) 1997-10-15
WO1996018650A1 (en) 1996-06-20
AU710150B2 (en) 1999-09-16
CA2207921A1 (en) 1996-06-20
GB9425502D0 (en) 1995-02-15
PL320747A1 (en) 1997-10-27
FI972558A (fi) 1997-06-16
JPH10511083A (ja) 1998-10-27
FI972558A0 (fi) 1997-06-16

Similar Documents

Publication Publication Date Title
BG103189A (en) Substituted 6,5-heterobicyclic derivatives
NL300808I1 (xx)
CA2278151A1 (en) Heregulin variants
ATE382681T1 (de) Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
EP1017713A4 (en) CYCLIC AGONISTS AND ANTAGONISTS OF THE C5A RECEPTORS AND G-PROTEIN COUPLED RECEPTORS
DK1765860T3 (da) Ny-ESO-T.cellereceptor med höj affinitet
EA200300462A1 (ru) Замещенные дипептиды в качестве средств, усиливающих секрецию гормона роста
NO974270L (no) Insulinderivater
ATE165395T1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
EA200100058A1 (ru) 4-бензилпиперидиналкилсульфоксидные гетероциклические соединения и их применение в качестве подтип-избирательных антагонистов nmda-рецепторов
BR0008056A (pt) Pirrolocarbazóis e isoindolonas cìclicas fundidas substituìdas
ES2194918T3 (es) Compuestos de tiazol y tiadiazol como ligando receptor de dopamina d3.
DK0772603T3 (da) Substituerede pyrimidinforbindelser og deres anvendelse
DK1360203T3 (da) Antistoffer mod ikke-funktionel P2X7-receptordiagnose og behandling af cancerlidelser og andre tilstande
DK0772604T3 (da) Trialzolforbindelser og deres anvendelse som dopamin-D3-ligander
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
DK1129186T3 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
DK1077941T3 (da) Forbindelser med væksthormonfrigörende egenskaber
NZ301916A (en) Monoclonal antibodies to il-5 for use as antagonists to il-5 related disorders
DK0754301T3 (da) Fremstilling og stabilisering af cellesuspensioner
CO5460266A1 (es) Novedosos analogos de la somatostatina
EA200000086A1 (ru) Алатрофлоксациновые парентеральные составы
BR0116686A (pt) Anticorpos anti-cd28 silenciados e uso dos mesmos
NO972771L (no) Ny reseptor
ES2147365T3 (es) Un procedimiento para la preparacion del factor ix a partir de muestras biologicas.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application